Familial adenomatosis of the colon: current state of the problem


Cite item

Full Text

Abstract

The urgency of the problem of familial adenomatosis of the colon (FAC) is caused both by the severity of the disease with the inevitable development of cancer without timely treatment, and the involvement of the patient's blood relatives in this problem. Due to the rare incidence of this disease, many issues require discussion. Aim. To determine the possibility of timely treatment of FAC patients maintaining a satisfactory quality of life. Materials and methods. The data on 5 FAC patients and 12 their blood relatives were studied. Clinical, endoscopic and genetic characteristics of the disease and treatment were analyzed. Results. demonstrated that family history, genetic and endoscopic examinations allow diagnosis of FAC. Colectomy with rectal resection and the creation of a small intestine reservoir with reservoir-rectal anastomosis provide a sufficient quality of life for patients. Examination of the patient's blood relatives reveals new patients requiring additional examination and treatment. Conclusion. The problem of FAC is multidisciplinary and involves therapists, gastroenterologists, pediatricians, geneticists, endoscopists, radiologists, surgeons and oncologists. Only a timely diagnosis can help the patient to undergo radical treatment before the development of colon cancer.

About the authors

O I Kit

Rostov Research Institute of Oncology, Ministry of Health of Russia

д.м.н., проф., член-корр. РАН, директор ФГБУ «Ростовский научно-исследовательский онкологический институт» Минздрава России (РНИОИ) Rostov-on-Don, Russia

Yu A Gevorkyan

Rostov Research Institute of Oncology, Ministry of Health of Russia

д.м.н., проф., зав. отд-нием абдоминальной онкологии №2 РНИОИ Rostov-on-Don, Russia

N V Soldatkina

Rostov Research Institute of Oncology, Ministry of Health of Russia

Email: snv-rnioi@yandex.ru
д.м.н., с.н.с. отд-ния абдоминальной онкологии №2 РНИОИ Rostov-on-Don, Russia

D A Haragezov

Rostov Research Institute of Oncology, Ministry of Health of Russia

к.м.н., хирург-онколог отд-ния абдоминальной онкологии №2 РНИОИ Rostov-on-Don, Russia

I Yu Efimova

Rostov Research Institute of Oncology, Ministry of Health of Russia

науч. сотр. лаб. молекулярной онкологии РНИОИ Rostov-on-Don, Russia

S I Poluektov

Rostov Research Institute of Oncology, Ministry of Health of Russia

хирург-онколог отд-ния абдоминальной онкологии №2 РНИОИ Rostov-on-Don, Russia

D O Kaymakchi

Rostov Research Institute of Oncology, Ministry of Health of Russia

хирург-онколог отд-ния абдоминальной онкологии №2 РНИОИ Rostov-on-Don, Russia

References

  1. Petersen G.M, Slack J, Nakamura Y. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology. 1991;100(6):1658-64.
  2. Kastrinosand F, Syngal S. Inherited Colorectal Cancer Syndromes. Cancer J. 2011;17(6):405-15.
  3. Talseth-Palmer B.A. The genetic basis of colonic adenomatous polyposis syndromes. Hered Cancer Clin Pract. 2017 Mar 16;15:5. doi: 10.1186/s13053-017-0065-x. eCollection 2017.
  4. Brosens L.A, van Hattem W.A, Jansen M, et al. Gastrointestinal polyposis syndromes. Curr Mol Med. 2007;7(1):29-46.
  5. Nielsen M, Hes F.J, Nagengast F.M, et al. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis. Clin Genet. 2007;71:427-33.
  6. Ефимова И.Ю., Тимошкина Н.Н., Солдаткина Н.В., Геворкян Ю.А., Водолажский Д.И. Молекулярная диагностика герминальных мутаций в гене АРС. В кн.: Сборник трудов IX Всероссийской научно - практической конференции с международным участием «Молекулярная диагностика 2017». Москва, 2017. Т.1. С.425-6.
  7. Wachsmannova-Matelova L, Stevurkova V, Adamcikova Z, Holec V, Zajac V. Different phenotype manifestation of familial adenomatous polyposis in families with APC mutation at codon 1309. Neoplasma. 2009;56(6):486-9.
  8. Ripa R, Bisgaard M.L, Bülow S, Nielsen F.C. De novo mutations in familial adenomatous polyposis (FAP). Eur J Hum Gen. 2002;10:631-63.
  9. Kastrinosand F, Syngal S. Inherited Colorectal Cancer Syndromes. Cancer J. 2011;17(6):405-15.
  10. Syngal S, Brand R.E, Church J.M, Giardiello F.M, Hampel H.L, Burt R.W. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110(2): 223-62; quiz 263.
  11. Stoffel E.M, Mangu P.B, Gruber S.B, Hamilton S.R, Kalady M.F, Lau M.W, Lu K.H, Roach N, Limburg P.J. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk - colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol. 2015;33(2):209-17.
  12. Кит О.И., Геворкян Ю.А., Солдаткина Н.В. Современные возможности колопроктологии: трансанальная эндоскопическая хирургия. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;25(4):86-91 [.
  13. Тарасов В.А., Матишов Д.Г., Шин Е.Ф., Бойко Н.В., Тимошкина Н.Н., Махоткин М.А., Ломоносов А.М., Кирпий А.А., Кит О.И., Максимов А.Ю. Аберрантная экспрессия микроРНК при развитии злокачественных опухолей толстой кишки. Генетика. 2014;50(10):1232.

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies